FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2970836103> ?p ?o ?g. }

• W2970836103 abstract "Purpose: Gender differences exist in the prevalence of asthma and allergic diseases, partially due to the effects of sex hormones on the development of allergic manifestations. Women, compared with men, are more prone to suffer allergic asthma, experience difficulties in controlling asthma symptoms, and show adverse responses to drugs. However, there are knowledge gaps on the effectiveness of anti-leukotrienes drugs on lung function, symptoms, and pulmonary and systemic inflammation in adult asthmatic women compared with men. We conducted a prospective cohort study to characterize the effectiveness of an anti-leukotrienes drug, montelukast (MS), in asthmatic adult women and men. Methods: Twenty-one asthmatic subjects (11 women and 10 men), who were on low-dose inhaled corticosteroids (ICS), were treated with MS. The optimal control of the symptoms was achieved in both groups according to the Global Initiative for Asthma guidelines. At enrollment, and after 13 weeks from the beginning of MS, pulmonary function tests and asthma control tests were performed, and the fraction of exhaled nitric oxide and blood eosinophils levels were measured. Results: From baseline until the end of the study, women treated with MS + ICS had better control of the asthmatic symptoms, defined as higher asthma control test (ACT) score (17.00 ± 1.07 to 23.36 ± 0.45; p < 0.0015), improved pulmonary function [with higher forced expiratory volume in 1 s (from 77.25 ± 6.79 to 103.88 ± 6.24; p < 0.0077)], and forced vital capacity (from 91.95 ± 6.81 to 113.17 ± 4.79; p < 0.0183) compared with men. Interestingly, MS + ICS-treated women had significantly lower levels of blood eosinophils (from 5.27 ± 0.30 to 3.30 ± 0.31; p < 0.0449) and exhaled nitric oxide (from 44.70 ± 7.30 to 25.20 ± 3.90; p < 0.0294) compared with men. Conclusion: The treatment with MS, added to ICS, in women leads to better control of symptoms, better management of lung function, and decreased inflammation levels compared with ICS + MS treatment in men." @default.
• W2970836103 created "2019-09-05" @default.
• W2970836103 creator A5000271049 @default.
• W2970836103 creator A5000508072 @default.
• W2970836103 creator A5003220471 @default.
• W2970836103 creator A5025153351 @default.
• W2970836103 creator A5025327744 @default.
• W2970836103 creator A5027647066 @default.
• W2970836103 creator A5029630616 @default.
• W2970836103 creator A5037733639 @default.
• W2970836103 creator A5045537168 @default.
• W2970836103 creator A5068424848 @default.
• W2970836103 creator A5068624791 @default.
• W2970836103 creator A5073131328 @default.
• W2970836103 creator A5081093006 @default.
• W2970836103 date "2019-09-24" @default.
• W2970836103 modified "2023-10-16" @default.
• W2970836103 title "Montelukast Improves Symptoms and Lung Function in Asthmatic Women Compared With Men" @default.
• W2970836103 cites W1540358156 @default.
• W2970836103 cites W1813993873 @default.
• W2970836103 cites W1925544883 @default.
• W2970836103 cites W1948288786 @default.
• W2970836103 cites W1965571580 @default.
• W2970836103 cites W1969040737 @default.
• W2970836103 cites W1971416778 @default.
• W2970836103 cites W1975045840 @default.
• W2970836103 cites W1987090231 @default.
• W2970836103 cites W1988686169 @default.
• W2970836103 cites W1999172455 @default.
• W2970836103 cites W2004334951 @default.
• W2970836103 cites W2007901041 @default.
• W2970836103 cites W2021893497 @default.
• W2970836103 cites W2025442131 @default.
• W2970836103 cites W2029251290 @default.
• W2970836103 cites W2030249068 @default.
• W2970836103 cites W2032751425 @default.
• W2970836103 cites W2043101861 @default.
• W2970836103 cites W2044151897 @default.
• W2970836103 cites W2066112262 @default.
• W2970836103 cites W2072500831 @default.
• W2970836103 cites W2085868451 @default.
• W2970836103 cites W2086332783 @default.
• W2970836103 cites W2090752608 @default.
• W2970836103 cites W2099997075 @default.
• W2970836103 cites W2113237775 @default.
• W2970836103 cites W2130917924 @default.
• W2970836103 cites W2135681037 @default.
• W2970836103 cites W2137070227 @default.
• W2970836103 cites W2141842086 @default.
• W2970836103 cites W2147120129 @default.
• W2970836103 cites W2155168486 @default.
• W2970836103 cites W2155991787 @default.
• W2970836103 cites W2161826873 @default.
• W2970836103 cites W2164854972 @default.
• W2970836103 cites W2166559145 @default.
• W2970836103 cites W2169632301 @default.
• W2970836103 cites W2233358057 @default.
• W2970836103 cites W2285332978 @default.
• W2970836103 cites W2510188126 @default.
• W2970836103 cites W2522909715 @default.
• W2970836103 cites W2529083728 @default.
• W2970836103 cites W2582510885 @default.
• W2970836103 cites W2590902165 @default.
• W2970836103 cites W2607120056 @default.
• W2970836103 cites W2611963161 @default.
• W2970836103 cites W2625701990 @default.
• W2970836103 cites W2738732235 @default.
• W2970836103 cites W2762347804 @default.
• W2970836103 cites W2886789767 @default.
• W2970836103 cites W2898925135 @default.
• W2970836103 cites W2900674435 @default.
• W2970836103 cites W817098076 @default.
• W2970836103 doi "https://doi.org/10.3389/fphar.2019.01094" @default.
• W2970836103 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6769077" @default.
• W2970836103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31611790" @default.
• W2970836103 hasPublicationYear "2019" @default.
• W2970836103 type Work @default.
• W2970836103 sameAs 2970836103 @default.
• W2970836103 citedByCount "14" @default.
• W2970836103 countsByYear W29708361032020 @default.
• W2970836103 countsByYear W29708361032021 @default.
• W2970836103 countsByYear W29708361032022 @default.
• W2970836103 countsByYear W29708361032023 @default.
• W2970836103 crossrefType "journal-article" @default.
• W2970836103 hasAuthorship W2970836103A5000271049 @default.
• W2970836103 hasAuthorship W2970836103A5000508072 @default.
• W2970836103 hasAuthorship W2970836103A5003220471 @default.
• W2970836103 hasAuthorship W2970836103A5025153351 @default.
• W2970836103 hasAuthorship W2970836103A5025327744 @default.
• W2970836103 hasAuthorship W2970836103A5027647066 @default.
• W2970836103 hasAuthorship W2970836103A5029630616 @default.
• W2970836103 hasAuthorship W2970836103A5037733639 @default.
• W2970836103 hasAuthorship W2970836103A5045537168 @default.
• W2970836103 hasAuthorship W2970836103A5068424848 @default.
• W2970836103 hasAuthorship W2970836103A5068624791 @default.
• W2970836103 hasAuthorship W2970836103A5073131328 @default.
• W2970836103 hasAuthorship W2970836103A5081093006 @default.
• W2970836103 hasBestOaLocation W29708361031 @default.
• W2970836103 hasConcept C126322002 @default.
• W2970836103 hasConcept C165637977 @default.

• next